X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (61) 61
life sciences & biomedicine (58) 58
humans (53) 53
1st-line treatment (46) 46
oncology (37) 37
female (32) 32
chemotherapy (30) 30
middle aged (23) 23
aged (22) 22
male (21) 21
open-label (17) 17
treatment outcome (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
adult (15) 15
antineoplastic agents - therapeutic use (14) 14
survival (13) 13
metastasis (12) 12
cancer (11) 11
1st-line chemotherapy (10) 10
care and treatment (10) 10
lung neoplasms - drug therapy (10) 10
aged, 80 and over (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
medicine & public health (9) 9
mutation (9) 9
umcg approved (9) 9
analysis (8) 8
breast neoplasms - drug therapy (8) 8
disease-free survival (8) 8
epidermal growth factor (8) 8
neoplasm metastasis (8) 8
patients (8) 8
pharmacology & pharmacy (8) 8
review (8) 8
risk factors (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
biomarkers (7) 7
double-blind (7) 7
growth-factor receptor (7) 7
lung neoplasms - genetics (7) 7
lung neoplasms - pathology (7) 7
multicenter (7) 7
research (7) 7
tumors (7) 7
angiogenesis inhibitors - therapeutic use (6) 6
bevacizumab (6) 6
breast neoplasms - pathology (6) 6
carcinoma, non-small-cell lung - genetics (6) 6
carcinoma, non-small-cell lung - pathology (6) 6
colorectal cancer (6) 6
gastroenterology & hepatology (6) 6
lung cancer (6) 6
phase-iii trial (6) 6
prognosis (6) 6
therapy (6) 6
time factors (6) 6
adenocarcinoma (5) 5
adolescent (5) 5
antineoplastic agents - adverse effects (5) 5
breast cancer (5) 5
cancer therapies (5) 5
cell lung-cancer (5) 5
clinical trials (5) 5
colorectal neoplasms - pathology (5) 5
disease progression (5) 5
drug resistance, neoplasm - genetics (5) 5
egfr (5) 5
health care sciences & services (5) 5
irinotecan (5) 5
medicine (5) 5
neoplasm staging (5) 5
phase-ii trial (5) 5
randomized-trial (5) 5
receptor, epidermal growth factor - antagonists & inhibitors (5) 5
studies (5) 5
survival rate (5) 5
trial (5) 5
acquired-resistance (4) 4
adjuvant chemotherapy (4) 4
age factors (4) 4
cancer patients (4) 4
capecitabine (4) 4
clinical medicine (4) 4
colon-cancer (4) 4
colorectal neoplasms - drug therapy (4) 4
colorectal neoplasms - mortality (4) 4
combination (4) 4
cost-benefit analysis (4) 4
cyclophosphamide (4) 4
efficacy (4) 4
gefitinib (4) 4
genetic aspects (4) 4
health aspects (4) 4
hypertension (4) 4
kaplan-meier estimate (4) 4
liver metastases (4) 4
lung cancer, non-small cell (4) 4
lung neoplasms - mortality (4) 4
metastases (4) 4
neoplasms (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 8, pp. 9309 - 9321
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2016, Volume 17, Issue 7, pp. 984 - 993
Journal Article
Blood, ISSN 0006-4971, 07/2005, Volume 106, Issue 1, pp. 35 - 39
...) as primary therapy in preparation for autologous peripheral blood stem-cell (PBSC) transplantation for multiple myeloma (MM... 
Life Sciences & Biomedicine | Hematology | Science & Technology
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 2017, Volume 55, pp. 16 - 25
Journal Article
PloS one, ISSN 1932-6203, 12/2018, Volume 13, Issue 12, pp. e0208994 - e0208994
Journal Article
Clinical cancer research, ISSN 1557-3265, 05/2017, Volume 23, Issue 9, pp. 2213 - 2222
Journal Article